Showing results (191-200 of 226) with videos related to

Sort By:
Pageof 23
Kidney International|May 16, 2019
Biological variation of measured and estimated glomerular filtration rate in patients with chronic kidney diseaseCeri Rowe, Alice J Sitch, Jonathan Barratt, et al.
Kidney International Reports|April 29, 2021
Rituximab in Membranous NephropathyPhilipp Gauckler, Jae Il Shin, Federico Alberici, et al.
Pediatric Nephrology (Berlin, Germany)|September 27, 2024
IPNA clinical practice recommendations for the diagnosis and management of children with IgA nephropathy and IgA vasculitis nephritisMarina Vivarelli, Susan Samuel, Rosanna Coppo, et al.
Ebiomedicine|July 14, 2026
Individualised treatment effects of corticosteroids in IgA nephropathyDavid L Hölscher, Nikolas E J Schmitz, Leon Niggemeier, et al.
Health Technology Assessment (Winchester, England)|July 26, 2024
Accuracy of glomerular filtration rate estimation using creatinine and cystatin C for identifying and monitoring moderate chronic kidney disease: the eGFR-C studyEdmund J Lamb, Jonathan Barratt, Elizabeth A Brettell, et al.
BMJ (Clinical Research Ed.)|March 19, 2026
Accuracy of glomerular filtration rate estimation based on creatinine and cystatin C for monitoring moderate chronic kidney disease in adults: prospective, longitudinal cohort studyKatie Scandrett, Alice J Sitch, Jonathan Barratt, et al.
BMJ Medicine|January 26, 2026
Test accuracy of glomerular filtration rate estimation with creatinine and cystatin C in adults with moderate chronic kidney disease: prospective cohort studyEdmund J Lamb, Jonathan Barratt, Elizabeth Ann Brettell, et al.
Computer Methods and Programs in Biomedicine|September 18, 2023
Performance and limitations of a supervised deep learning approach for the histopathological Oxford Classification of glomeruli with IgA nephropathyNicola Altini, Michele Rossini, Sándor Turkevi-Nagy, et al.
Annals of the Rheumatic Diseases|March 23, 2023
Rituximab versus azathioprine for maintenance of remission for patients with ANCA-associated vasculitis and relapsing disease: an international randomised controlled trialRona M Smith, Rachel B Jones, Ulrich Specks, et al.
The New England Journal of Medicine|March 30, 2026
Iptacopan in IgA Nephropathy - Final 24-Month DataJonathan Barratt, Necmi Eren, Naoki Kashihara, et al.
Pageof 23